Appointment of Director & Appendix 3X

Aug 1, 2018
Posted in: News, Investor updates

Home » Appointment of Director & Appendix 3X

Appointment of Director & Appendix 3X

Aug 1, 2018
Posted in: News, Investor updates

Appendix 3X (Initial Director’s Interest Notice) in relation to the appointment of Dr. Hazle effective July 30th, 2018.
View and download Appointment of Director and Appendix 3X.

Join Us at RSNA and SABCS: Advancing Molecular MRI for Cancer Detection

November 13, 2025

We are excited to announce that Imagion Biosystems (ASX: IBX) will be attending two premier medical conferences this fall: the Radiological Society of North

Positive Results Received from WSU on MagSense® Dosage – Phase 2 Clinical Trial on HER2 Breast Cancer Imaging Agent

November 5, 2025

FDA Submission of IND for MagSense® HER2 Phase 2 Clinical Trial on Track Q4 2025 Key Highlights: Wayne State University Collaboration Program Delivers Positive and

[Video] The Market Bull – Imagion Biosystems’ Magsense Non-invasive Cancer Detection

October 24, 2025

Video transcript: Advances in treatment for cancer have greatly improved survivability when the cancer is caught early. However, despite global spending of over $100

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.

Appointment of Director & Appendix 3X

Appointment of Director & Appendix 3X

Related Articles

Join Us at RSNA and SABCS: Advancing Molecular MRI for Cancer Detection

Positive Results Received from WSU on MagSense® Dosage – Phase 2 Clinical Trial on HER2 Breast Cancer Imaging Agent

[Video] The Market Bull – Imagion Biosystems’ Magsense Non-invasive Cancer Detection

Transforming medical imaging for early disease detection

About Imagion Biosystems

Contact us

Join our email list